Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

OSE Pharma S.A.. (9/1/15). "Press Release: OSE Pharma Sets Up Scientific Steering Committee and Takes a First Step in the Launch of Its Phase 3 Trial in Lung Cancer [Not for US, CA, AU or JP]". Paris.

Organisations Organisation OSE Pharma S.A.
  Today OSE Immunotherapeutics S.A.
  Group OSE Immunotherapeutics (Group)
  Organisation 2 Institut Gustave Roussy (IGR)
Products Product Tedopi® cancer immunotherapy
  Product 2 clinical research
Persons Person Costantini, Dominique (OSE Pharma 201504 CEO + Co-founder + former CEO + Co-founder of BioAlliance Pharma in 1997)
  Person 2 Bault, Laurence (Huntsworth 201506 at Citigate Dewe Rogerson Paris)
     


   
Record changed: 2019-04-26

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for OSE Immunotherapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px




» top